Evidence map›Paper›PMID 42886496›Full record

ArticleJAMA health forum2026

Psychotherapy and Antidepressant Use After the US Preventive Services Task Force-Recommended Depression Screening.

Sonia M Tetlow, Benjamin G Druss

Abstract read
In one paragraph

Article in JAMA health forum, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Sonia M TetlowDepartment of Health Policy and Management, Emory University, Atlanta, Georgia.
Benjamin G DrussDepartment of Health Policy and Management, Emory University, Atlanta, Georgia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Importance: Fewer than one-third of adults with depression receive any treatment for depression. It is important to evaluate the association between the 2016 US Preventive Services Task Force (USPSTF) recommendation and depression treatment nationally. Objective: To examine changes in the likelihood of psychotherapy and antidepressant use after the USPSTF-recommended routine adult depression screening. Design, Setting, and Participants: This policy evaluation used a single-group, interrupted time series design with logistic regression. Medical Expenditure Panel Survey Household Component data from 2008 to 2023 were analyzed from November 3, 2025, to March 31, 2026. The sample included adults aged 18 years and older. Exposure: 2016 USPSTF grade B recommendation for routine adult depression screening. Main Outcomes and Measures: Likelihood of psychotherapy or antidepressant use immediately (level change) and over time (post-USPSTF slope change [trend]) using an interrupted time series design and logistic regression models. Results: The analysis included 372 962 adults. Using the Medical Expenditure Panel Survey person-level survey weights, this corresponded to a nationally representative sample of 244 316 623 adults (median age, 47 years; IQR, 32-61 years; 51.6% female). The recommendation was associated with a significant level increase (odds ratio [OR], 1.18; 95% CI, 1.02-1.37) and post-USPSTF trend (OR, 1.08; 95% CI, 1.04-1.11) increase in the likelihood of psychotherapy only, level (OR, 0.88; 95% CI, 0.82-0.94) and post-USPSTF trend (OR, 0.98; 95% CI, 0.96-0.99) decreases in the likelihood of antidepressants only, and no significant changes in combined treatment among adults overall. By psychological distress level, it was associated with a significant level increase in the likelihood of psychotherapy only (OR, 1.63; 95% CI, 1.10-2.41) and post-USPSTF trend decrease in the likelihood of antidepressants only (OR, 0.94; 95% CI, 0.89-0.98) among adults reporting serious distress, significant level (OR, 1.38; 95% CI, 1.15-1.66) and post-USPSTF trend (OR, 1.05; 95% CI, 1.01-1.10) increases in the probability of psychotherapy only, and level (OR, 0.88; 95% CI, 0.81-0.96) and post-USPTF trend (OR, 0.96; 95% CI, 0.94-0.98) decreases in the likelihood of antidepressants only among adults reporting mild or moderate distress, and no significant changes among adults reporting no distress. There was a significant level decrease (OR, 0.79; 95% CI, 0.70-0.89) in the probability of seeing a prescriber for psychotherapy after the recommendation. Conclusions and Relevance: This study found that the USPSTF recommendation for routine adult depression screening was associated with increased likelihood of psychotherapy and decreased likelihood of antidepressant use among adults reporting some level of psychological distress. Findings suggest no association with unnecessary treatment among adults with low levels of distress.

Indexed as

Antidepressive AgentsDepressionMass ScreeningPreventive Health ServicesPsychotherapyAdultAdvisory CommitteesFemaleHumansLogistic ModelsMaleMiddle AgedUnited StatesAntidepressive Agents

Identifiers

PMID42886496
PMCPMC13675826

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.